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Background: Caseous lymphadenitis (CL) is a contagious infectious disease of small ruminants caused by
Corynebacterium pseudotuberculosis. Is characterized by the formation of abscesses in the lymph nodes and
intestines of infected animals, induced by inflammatory cytokines. The production of cytokines, such as IL-10,
TNF-α, IL-4 and IFN-γ, is regulated by mitogen-activated protein kinase (MAPK) pathway activation. The present
study investigated the involvement of MAPK pathways (MAPK p38, ERK 1 and ERK 2) with respect to the
production of cytokines induced by antigens secreted by C. pseudotuberculosis over a 60-day course of infection.
CBA mice (n = 25) were divided into three groups and infected with 102 colony forming units (CFU) of attenuated
strain T1, 102 CFU of virulent strain VD57 or sterile saline solution and euthanized after 30 or 60 days. Murine
splenocytes were treated with specific inhibitors (MAPK p38 inhibitor, ERK 1/2 inhibitor or ERK 2 inhibitor) and
cultured with secreted antigens obtained from pathogenic bacteria (SeT1 or SeVD57).
Results: The MAPK pathways evaluated were observed to be involved in the production of IL-10, under stimulation by
secreted antigens, while the MAPK p38 and ERK 1 pathways were shown to be primarily involved in TNF-α production.
By contrast, no involvement of the MAPK p38 and ERK 1 and 2 pathways was observed in IFN-γ production, while the
ERK 2 pathway demonstrated involvement in IL-4 production only in the mouse splenocytes infected with VD57 under
stimulation by SeT1.
Conclusion: The authors hypothesize that MAPK p38 and ERK 1 pathways with respect to TNF-α production,
as well as the MAPK p38 and ERK 1 and 2 pathways in relation to IL-10 production under infection by C.
pseudotuberculosis are important regulators of cellular response. Additionally, the lack of the MAPK p38 and
ERK 1/2 pathways in IFN-γ production in infected CBA murine cells stimulated with the two secreted/excreted
antigens, in IL-4 production showing involvement only via the ERK 2 pathway under stimulation by SeT1
antigen during 60-day infection period with the virulent strain, suggests that these pathways regulated the
production of pro-inflammatory and regulatory cytokines in the splenic cells of CBA mice.
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Corynebacterium pseudotuberculosis is a minuscule,
Gram-positive, pleomorphic, non-sporulating facultative
anaerobic bacillus. Belonging to the genus Corynebacteria-
ceae (Actinomycetae), which includes the genera Rhodococ-
cus and Mycobacterium, it is known to be a causative agent
of caseous lymphadenitis (CL) in small ruminants, such as
goats and sheep [1,2].
CL is a chronic infectious disease characterized by the
formation of granulomas. Infection primarily involves the
skin and affected mucosa, followed by the spread of either
free bacteria or those inside phagocytes, leading to local-
ized infection in the lymph nodes or internal organs [3].
Once successfully established within the host, chronic
infection may persist throughout most, or even the en-
tire lifespan of the animal [4]. This disorder compro-
mises the animal’s skin, skeleton and internal organs, in
addition to reducing wool production, limiting weight
gain and reproductive efficiency, resulting in reduced
birth rates of offspring [5,6] and severe economic hard-
ship for livestock producers, especially small farmers.
The adaptive resistance to infection caused by faculta-
tive intracellular bacteria, such as C. pseudotuberculosis,
is related to CD4 T cells and, more specifically, to clones
that produce Th1-type cytokines, mainly IFN-γ and
TNF-α. These pro-inflammatory cytokines increase the
bactericidal activity of macrophages and activate CD8 T
lymphocytes [7,8].
One of the main characteristics of pathogenic mycobac-
teria is its capability to tolerate and manipulate host im-
mune response, thereby promoting intracellular pathogen
survival [9,10]. Initial interactions between macrophages
and mycobacteria result in the activation of the intracellu-
lar signaling pathway, whereby events mediated by recep-
tors are associated with transcriptional responses and
protein translation [11].
The mitogen-activated protein kinases (MAPK) are a
subfamily of serine/threonine-specific protein kinases.
MAPKs are expressed by all cell types and respond to
extracellular stimuli (mitogens) that mediate signal trans-
duction from cell surface receptors to nuclei [12,13].
MAPKs, part of a phosphorylation system in which three
kinases are sequentially activated [14,15], are expressed in
mammalian cells and translate signals in response to
growth factors, pro-inflammatory cytokines and stress
conditions.
Three subfamilies of MAPKs have been well-
characterized: MAPK p38, which contains four iso-
forms (α, β, γ, and δ); ERK, the kinase regulated by
extracellular signaling, with isoforms p44 (ERK1) and
p42 (ERK2); and the protein kinase c-jun N-terminal,
with isoforms, JNK 1, JNK 2 and JNK 3 [16,17].
MAPK p38 regulates the expression of several cyto-
kines, is activated in immune cells by inflammatorycytokines, and plays an important role in the activation of
host immune response [18]. ERK 1 and 2 are widely
expressed and involved in the regulation of meiosis, mi-
tosis and post-mitotic functions in a variety of cells.
Cytokines are among the many different stimuli capable
of activating the ERK 1 and ERK 2 pathways [19,20]. In
addition, MAPK p38 shares about 50% of its homology
with ERK [21], suggesting that these two pathways may
play similar roles during host immune response.
The present study employed CBA mouse splenocytes
to evaluate the potential involvement of the mitogen-
activated protein kinases MAPK p38 and ERK1 and 2
with respect to selected in vitro cytokine production
under stimulation by antigens secreted/excreted by C.
pseudotuberculosis.
Results and discussion
Action of mitogen-activated protein kinase specific
inhibitors on the production of TNF-α under stimulation
by C. pseudotuberculosis antigens
An analysis of the group of CBA mice infected with the
virulent VD57 strain of C. pseudotuberculosis for 30 days
revealed a statistically significant inhibition (P = 0.016) of
TNF-α production. This was induced only by the MAPK
p38 (Inhib 1) and ERK 1/2 (Inhib 2) inhibitors under
stimulation by both virulent and attenuated secreted/ex-
creted antigens. However, also at 30 days after infection,
cells obtained from the group of animals infected with the
attenuated T1 strain showed no statistically significant in-
hibition in TNF-α production following treatment with
MAPK inhibitors under stimulation by secreted antigens
(Figure 1).
In the group of mice infected with the virulent strain for
60 days, a statistically significant inhibition (P = 0.009) in
TNF-α production was observed in the splenic cultures
treated with each of the three MAPK inhibitors under
stimulation by SeT1. However, in the treated cells that
were stimulated with SeVD57, a statistically significant
decrease (P = 0.009) in TNF-α was observed only in those
cultures treated with the ERK 1/2 inhibitor. In the group
of mice infected with the attenuated strain for 60 days,
statistically significant inhibition (P = 0.009) of TNF-α was
also observed in cultures treated with any one of the three
inhibitors under stimulation with SeT1. By contrast, under
stimulation by SeVD57, a statistically significant reduction
(P = 0.009) in TNF-α production was observed only in the
groups treated with the MAPK p38 and ERK1/2 inhibitors
(Figure 2).
Action of mitogen-activated protein kinase specific
inhibitors on the production of IFN-γ under stimulation
by C. pseudotuberculosis antigens
After 30 days of infection with either the virulent or atten-
uated strain of C. pseudotuberculosis, no statistically
Figure 1 Effect of MAPK pathway inhibitors MAPK p38 (Ini I), ERK
1 / 2 (Ini II) and ERK 2 (Ini III) on the production of TNF-α by
splenic cells obtained from CBA mice after 30 days of infection
with virulent (VD57) and attenuated (T1) C. pseudotuberculosis
strains, under stimulation by secreted/excreted antigens (SeT1
and SeVD57). Each experiment was carried out ≥3 times in
triplicate. *p < 0.05 with respect to stimulation by SeT1; # p < 0.05
with respect to stimulation by SeVD57.
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CBA cells treated with any of the three MAPK inhibitors
and subsequently stimulated with secreted antigens from
either strain (Figure 3).
Similar results were obtained after 60 days of infection
with both the virulent and attenuated strains, as no statis-
tically significant inhibition of IFN-γ was observed in the
cells treated with any of the three MAPK inhibitors
followed by stimulation with secreted antigens (Figure 4).Figure 2 Effect of MAPK pathway inhibitors MAPK p38 (Ini I), ERK
1 / 2 (Ini II) and ERK 2 (Inb III) on the production of TNF-α by
splenic cells obtained from CBA mice after 60 days of infection
with virulent (VD57) and attenuated (T1) C. pseudotuberculosis
strains, under stimulation by secreted/excreted antigens (SeT1
and SeVD57). Each experiment was carried out ≥3 times in
triplicate. *p < 0.05 with respect to stimulation by SeT1; # p < 0.05
with respect to stimulation by SeVD57.Action of mitogen-activated protein kinase specific
inhibitors on the production of IL-10 under stimulation
by C. pseudotuberculosis antigens
After 30 days of infection with the virulent VD57 strain, a
statistically significant decrease (P = 0.008) was observed
in IL-10 production by splenic cells pretreated with any
one of the three MAPK inhibitors and then subsequently
stimulated with the SeT1 antigen. When stimulated
with SeVD57, a statistically significant reduction in IL-10
(P = 0.009) was observed when the MAPK p38 and ERK
1/2 pathways were inhibited. Mice infected for 30 days
with the attenuated T1 strain showed a significant reduc-
tion (P = 0.028) in IL-10 production only when the ERK
1/2 inhibitor was applied in conjunction with stimula-
tion by SeT1 (Figure 5).
At 60 days after infection with both virulent and attenu-
ated strains, all three MAPK inhibitors induced statisti-
cally significant decreases (P = 0.009) in IL-10 production
under stimulation by secreted/excreted antigens. The only
exception was cells infected with the attenuated strain,
which were treated with ERK 2 inhibitor and stimulated
by SeVD57 (Figure 6).Action of mitogen-activated protein kinase specific
inhibitors on the production of IL-4 under stimulation by
C. pseudotuberculosis antigens
After 30 days of infection with both the virulent and atten-
uated strains, no statistically significant decreases in IL-4
production were observed in any cell cultures treated with
MAPK inhibitors under stimulation by either SeT1 or
SeVD57 antigens (Figure 7). Interestingly, after 60 days of
infection, a statistically significant inhibition (P = 0.047)
was detected in cells infected with the virulent VD57 strain
and treated with the ERK 2 inhibitor under stimulation by
SeT1 (Figure 8).
The data presented herein strongly suggest that,
under the experimental protocol described above, the
main pathways involved in the production of TNF-α
are MAPK p38 and ERK 1. In addition, the present
study also demonstrated the involvement of the MAPK
p38 and ERK 1 and 2 pathways with respect to the pro-
duction of IL-10. Recent studies have suggested that
the MAPK signaling pathway is essential to the produc-
tion of pro-inflammatory cytokines, such as TNF-α and
IL-10 [22,23]. The activation of the MAPKs pathway
varies in terms frequency and extent in accordance with
pathogen species and degree of virulence [24,25].
After infection for 30 days with the virulent VD57
strain, the data herein suggest that the MAPK p38 and
ERK 1 pathways are involved in the production of TNF-α
when stimulated by secreted/excreted antigens. By con-
trast, none of the MAPKs pathways appeared to be in-
volved in TNF-α production after 30 days of infection by
the attenuated T1 strain. Nonetheless, after 60 days of in-
fection under stimulation by the SeT1 antigen, all three
analyzed MAPK pathways demonstrated involvement in
Figure 3 Effect of MAPK pathway inhibitors MAPK p38 (Ini I), ERK
1 / 2 (Ini II) and ERK 2 (Inb III) on the production of IFN-γ by
splenic cells obtained from CBA mice after 30 days of infection
with virulent (VD57) and attenuated (T1) C. pseudotuberculosis
strains, under stimulation by secreted/excreted antigens (SeT1
and SeVD57). Each experiment was carried out ≥3 times
in triplicate.
Figure 4 Effect of MAPK pathway inhibitors MAPK p38 (Ini I),
ERK 1 / 2 (Ini II) and ERK 2 (Inb III) on the production of IFN-γ
by splenic cells obtained from CBA mice after 60 days of
infection with virulent (VD57) and attenuated (T1) C.
pseudotuberculosis strains, under stimulation by secreted/
excreted antigens (SeT1 and SeVD57). Each experiment was
carried out ≥3 times in triplicate.
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lated with the SeVD57 antigen for 60 days, the MAPK p38
and ERK 1 pathways demonstrated involvement in cyto-
kine production, while the ERK 2 pathway did not.
A previous study conducted by Sim et al. [26] found
that in vitro infection by M. avium in the monocytes of
healthy patients was able to successfully activate the
MAPK p38 and ERK 1/2 pathways and positively regu-
late TNF-α production. However, this same study also
employed monocytes from diseased patients with M.
abscessus and found that in vitro infection with M.
avium decreased the expression of MAPK p38 and ERK
1/2, in addition to reducing TNF-α production.
Basler et al. [27] investigated the production of TNF-α
by murine macrophages infected withM. avium subspecies
paratuberculosis (pathogenic) and M. smegmatis (non-
pathogenic) using MAPK p38 (SB203580) inhibitors. These
authors found that the MAPK p38 pathway was indeed in-
volved in TNF-α production, with low levels observed
under infection by the pathogenic species. According to
their findings, the induced decrease in TNF-α by patho-
genic mycobacteria was associated with a reduction in the
duration and extent of MAPK p38 phosphorylation.
Other studies have demonstrated the importance of
the pro-inflammatory cytokine TNF-α, most notably at
the site of infection [28,29]. As such, the blocking of
TNF-α by monoclonal antibodies inhibits the formation
of well-differentiated granulomas in experimental infec-
tion models employing M. tuberculosis, resulting in the
dissemination of the pathogen [30,31].
According to Rocco and Irane [32], the interference
of intracellular signaling is fundamental to the strat-
egy of virulence of intracellular pathogens, such as
M. tuberculosis and M. avium.The aforementioned study by Sim et al. [26] reported on
the importance of the activation of the MAPK p38 and
ERK 1/2 pathways with respect to TNF-α production.
These authors demonstrated that the insufficient activa-
tion of the MAPK p38 pathway in response to pathogenic
mycobacteria may represent an important mechanism,
due to the negative regulation of host immune response,
thus allowing the pathogen to persist intracellularly.
With respect to the involvement of the three evaluated
MAPK pathways in the production of IL-10, the findings
presented herein are in partial agreement with the data
presented by Méndez-Samperio et al. [33]. Theses authors
treated human lung epithelial cells with the SB203580
MAPK p38 inhibitor, demonstrating the involvement of
MAPK p38 signaling in the secretion of IL-10 following in-
fection with M. bovis BCG cells. However, this same study
also used PD98059 to inhibit the MEK (MAPK / ERK)
pathway and found that this pathway was not involved in
IL-10 production, which is known to be responsible for the
phosphorylation and subsequent activation of ERK.
According to Souza et al. [11], blocking the MAPK p38
pathway with SB203580 prior to infecting bovine mono-
cytes with M. avium subspecies paratuberculosis resulted
in decreased IL-10 expression. Elevated IL-12 expression
was also observed along with increased acidification of
phagocytes and a reinforcement of parasite killing, sug-
gesting that the overproduction of IL-10 mediated by the
MAPK p38 pathway may play an important role in the
mitigation of antimicrobial activity by phagocytes. This
association constitutes a key mechanism involved in the
capability of M. avium subsp. paratuberculosis to survive
in bovine monocytes.
IL-10 is known to inhibit the transcription and
production of pro-inflammatory cytokines, such as TNF-α
Figure 5 Effect of MAPK pathway inhibitors MAPK p38 (Ini I),
ERK 1 / 2 (Ini II) and ERK 2 (Inb III) on the production of IL-10
by splenic cells obtained from CBA mice after 30 days of
infection with virulent (VD57) and attenuated (T1) C.
pseudotuberculosis strains, under stimulation by secreted/
excreted antigens (SeT1 and SeVD57). Each experiment was
carried out ≥3 times in triplicate. *p < 0.05 with respect to
stimulation by SeT1; # p < 0.05 with respect to stimulation
by SeVD57.
Figure 6 Effect of MAPK pathway inhibitors MAPK p38 (Ini I),
ERK 1 / 2 (Ini II) and ERK 2 (Inb III) on the production of IL-10
by splenic cells obtained from CBA mice after 60 days of
infection with virulent (VD57) and attenuated (T1) C.
pseudotuberculosis strains, under stimulation by secreted/
excreted antigens (SeT1 and SeVD57). Each experiment was
carried out ≥3 times in triplicate. *p < 0.05 with respect to
stimulation by SeT1; # p < 0.05 with respect to stimulation
by SeVD57.
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and inhibit the proliferation of T cells that produce
IFN-γ [34]; as such, this cytokine clearly suppresses the
Th1 response.
Taken together, the findings presented in previous stud-
ies indicate that the early activation of the MAPK p38
pathway may be a common mechanism by which virulent
mycobacterial organisms suppress the antimicrobial re-
sponse of susceptible host cells, allowing pathogens to
persist intracellularly.
The activation of the MAPK p38 signaling pathway
leads to rapid IL-10 expression under infection by intra-
cellular bacteria, which in turn attenuates antimycobacter-
ial activity, including the production of proinflammatory
cytokines and phagosome maturation. Thus, it is possible
that further manipulation of the MAPK p38 pathway may
lead to a better understanding of the escape mechanisms
used by C. pseudotuberculosis to evade host immune re-
sponse during infection.
The data presented herein suggest that none of the
MAPK pathways studied were involved in the produc-
tion of IFN-γ. This finding is unsurprising, as the litera-
ture contains various studies showing the involvement
of MAPK p38 and ERK 1/2 in the production of pro-
inflammatory and/or regulatory cytokines in experimen-
tal models that employ a variety of intracellular parasites
[25,35,36].
IL-4 production was observed to involve only the ERK
2 pathway in CBA mice after 60 days of infection with
the virulent strain under stimulation by the SeT1 anti-
gen. This finding suggests the differential involvement of
a cascade of cellular signaling in response to virulent
and attenuated C. pseudotuberculosis at various infectiontimes. These differences in pathway activation may result
from the differential expression of molecular compounds
by the two strains considered herein, which are then rec-
ognized by macrophage receptors.
Conclusion
The present study serves to contribute to the working body
of knowledge on the interaction of C. psedotuberculosis and
immune resonse of the host, as it clearly demonstrates the
importance of the MAPK p38 and ERK 1 pathways with re-
spect to TNF-α production, as well as the MAPK p38 and
ERK 1 and 2 pathways in relation to IL-10 production
under infection by C. pseudotuberculosis, providing evi-
dence that the respective signaling pathways are important
regulators of cellular response to this pathogen.
Additionally, the lack of involvement of the MAPK p38
and ERK 1/2 pathways in IFN-γ production in infected
CBA murine cells stimulated with the two secreted/ex-
creted antigens, considered in conjunction with the produc-
tion of IL-4 showing involvement only via the ERK 2
pathway under stimulation by SeT1 antigen during 60-day
infection period with the virulent strain, suggests that these
signaling pathways may cooperate to regulate the produc-
tion of only pro-inflammatory and regulatory cytokines in
the splenic cells of CBA mice. Further studies should be
conducted to validate this hypothetical assumption.
Methods
C. pseudotuberculosis strain selection
The present study employed attenuated and virulent
strains of C. pseudotuberculosis, T1 and VD57, respect-
ively. Both of these were isolated from the granuloma of
Figure 8 Effect of MAPK pathway inhibitors MAPK p38 (Ini I),
ERK 1 / 2 (Ini II) and ERK 2 (Inb III) on the production of IL-4 by
splenic cells obtained from CBA mice after 60 days of infection
with virulent (VD57) and attenuated (T1) C. pseudotuberculosis
strains, under stimulation by secreted/excreted antigens (SeT1
and SeVD57). Each experiment was carried out ≥3 times in
triplicate. *p < 0.05 with respect to stimulation by SeT1.
Figure 7 Effect of MAPK pathway inhibitors MAPK p38 (Ini I),
ERK 1 / 2 (Ini II) and ERK 2 (Inb III) on the production of IL-4 by
splenic cells obtained from CBA mice after 30 days of infection
with virulent (VD57) and attenuated (T1) C. pseudotuberculosis
strains, under stimulation by secreted/excreted antigens (SeT1
and SeVD57). Each experiment was carried out ≥3 times
in triplicate.
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in northeastern Brazil, and then stored in the Department
of Microbiology collection center at the Health Sciences
Institute of the Federal University of Bahia (ICS-UFBA).
The strain T1, had its identification confirmed by
Gram staining, colony morphology, synergistic hemolytic
activity with CAMP factor of Rhodococcus equi, urease
and catalase production. A commercial kit to perform a
more reliable identification was also used (API Coryne -
bioMérieux). According to previous studies, this strain
can’t induce disease in goats [37,38] and mice [8], and
was used as a vaccinal strain [39]. Furthermore, during
the synergistic hemolysis test, we observed a pattern of
less severe hemolysis when compared with other wild
strains.
The pathogenic strain, employed as a challenge to vacci-
nated animals, was named VD57, and had a similar identi-
fication process as the attenuated strain. This strain
induces caseous lymphadenitis in goats [38-40] and mice
[8]. The bacteria were grown in the ICS-UFBA microbiol-
ogy department laboratory in Brain Heart Infusion (BHI)
broth. Then the strains T1 and VD57 they were cultured
for 72 hours at 37°C to obtain secreted antigens (SeT1 and
SeVD57, respectively). Cultures were also later used to
infect experimental animals.
Obtainment of secreted/excreted antigens
Bacterial culture supernatants were collected following
centrifugation at 12,000 xg for 30 minutes at 4°C.
Bacteria-free supernatant was filtered using a 0.2 μm
membrane, followed by the gradual addition of 30% am-
monium sulfate (176 g/liter). pH values were measured
immediately thereafter and adjusted as necessary to 4.0using concentrated HCl. Next, n-butanol was added in
an identical proportion to the volume of obtained
supernatant. Following vortex agitation for one minute
and one hour of rest at room temperature (24°C), the
protein fraction was precipitated at the interface and
collected, then resuspended in PBS and centrifuged at
1350 xg for 10 minutes. Dialysis was subsequently per-
formed on the obtained media in a diluted 3 M phos-
phate buffer (ratio: 20 mL of buffer to 1 L of distilled
water) using a cold chamber for 48 hours. The obtained
antigen protein concentration was determined using
the Lowry method in accordance with manufacturer
guidelines (Bio-Rad, Hercules, CA).Animals and experimental infection protocol
Twenty-five 60-day-old male and female CBA mice were
supplied by the Gonçalo Moniz Research Center (FIO-
CRUZ - BA) animal care facility. All animals were kept in
cages in a pathogen-free environment under controlled
temperature, humidity and light conditions, and were fed
a balanced diet of rations and distilled water ad libitum.
The experimental infection protocol entailed the intraperi-
toneal injection of 10 animals with 102 colony forming
units (CFU) of T1 C. pseudotuberculosis and 10 animals
with 102 CFU of the VD57 strain, while five control mice
received sterile saline injections. After 30 days, five of each
mouse group infected with either T1 or VD57 were sacri-
ficed to assess cytokine production in vitro, and this same
procedure was repeated at 60 days with the remaining ani-
mals. The present study was approved by the Institutional
Animal Care and Use Committee of the Federal University
of Bahia (Protocol number 006/2010).
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Infected mouse spleens were aseptically removed and
washed twice in RPMI 1640 medium (Sigma). Spleen cells
were collected by divulsion and placed in RPMI medium
(3 mL) supplemented with 10% fetal bovine serum and 1%
antibiotic (penicillin and streptomycin). Obtained cells
were diluted at 1:100 (30 μl of acetic acid, 960 μl of trypan
blue stain and 10 μl of cells) and counted in a Neubauer
chamber to determine cellular viability as well as to adjust
concentration levels. Splenic cells were then cultured in
24-well plates at a final concentration of 106 cells per mL.
Treatment of splenocytes with MAPK p38 and ERK 1/2
inhibitors
Splenic cell cultures were exposed to the following specific
inhibitors (Biosource/Life Technologies, Grand Island,
USA): 1) SB203580 (MAPK p38 inhibitor); 2) U0126 (ERK
1/2 inhibitor) or 3) ERK activation inhibitor peptide I (ERK
2 inhibitor) at a concentration of 40nM for one hour before
stimulation with secreted antigens (SeT1 or SeVD57).
Splenocyte stimulation using secreted/excreted antigens
One of the following two C. pseudotuberculosis antigens
were added to the plate wells: SeT1 (attenuated strain
secretion) or SeVD57 (wild-type strain secretion) at a
concentration of 40 μg/mL. Pokeweed mitogen (PWM)
was used at a concentration of 2.5 μg/mL for positive con-
trols, while non-stimulated cells (antigens) were used as
negative controls.
Following stimulation, all well plates were incubated for
120 hours (at 37°C and 5% CO2), then collected. After cen-
trifugation, the culture supernatants were stored at −20°C
until the time of cytokine quantification.
Cytokine quantification
The levels of cytokines TNF-α, IFN-γ, IL10 and IL-4 were
measured in the culture supernatants by the “sandwich”
ELISA technique using commercial kits from R&D
(Minneapolis, USA) in accordance with manufacturer
guidelines as summarized below:
Plates (Costar/Corning, Tewksbury, USA) were sensi-
tized with 100 μL/well of capture antibody diluted in fil-
tered PBS and incubated overnight at room temperature
(24°C). The plates were then washed ten times with
PBS-T (this same washing procedure was used repeat-
edly at each stage). Blocking was performed with 2%
PBS-BSA for 2 h at room temperature (this same incu-
bation procedure was employed at all stages). Next, the
plates were washed, 100 μL of samples, control or
standard dilutions per well (diluted in 1% PBS-BSA) at
concentrations of 2000 pg/mL, 1000 pg/mL, 500 pg/mL,
250 pg/mL, 125 pg/mL, 62.5 pg/mL, 31.2 pg/mL for
IFN-γ, IL10 and TNF-α; while for IL-4 the followingconcentrations were used: 1000 pg/mL, 500 pg/mL,
250 pg/mL, 125 pg/mL, 62.5 pg/mL 31.2 pg/mL, 15.6 pg/
mL. Next, all plates were incubated for 2 h and immedi-
ately washed, followed by the addition of a detection
antibody diluted in 1% PBS-BSA (100 μL/well) and an
additional incubation period of 2 h. After washing, conju-
gated streptavidin-HRP was diluted at 1:200 and then
added to each well (100 μl), followed by a 20-minute incu-
bation period. Immediately thereafter, all plates were
washed again, tetramethylbenzidine (TMB) liquid sub-
strate was added (100 μL per well), followed by a subse-
quent incubation period of 20 minutes in a light-free
environment. Next, 50 μL of stop solution (2 N H2SO4)
was added to each well and photocolorimetric readings
were taken using 450 to 620 nm filters in a microplate
reader (Bio-Rad, Hercules, CA).Statistical analysis
All data from two experimental infection groups and five
control mice were analyzed using SPSS (Statistical Pack-
age for Social Sciences) version 9.0 for Windows. The
nonparametric Kruskal-Wallis test was used to compare
means among groups, while the Mann–Whitney U-test
was employed to make pairwise comparisons among
independent groups. Results were considered statistically
significant when p < 0.05.
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